Actively Recruiting
Evaluating the Effects of Oral Skin Supplements on Skin Health and Aging Biomarkers in Healthy Adults Aged 35 to 65
Led by Amazentis SA · Updated on 2026-09-22
90
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the impact of two oral skin nutritional supplements compared to a placebo on changes in skin aging biomarkers. The study focuses on healthy adults aged 35 to 65 years who show visible signs of facial skin aging. The purpose is to better understand how these supplements may affect skin health and aging processes over an 8-week period. Participants will be randomly assigned to one of several groups receiving either active softgel supplements with placebo powder, active comparator powder with placebo softgels, or placebo softgels and placebo powder. The supplements are taken once daily with water, and the study is designed as a double-blind, randomized, double-dummy, controlled trial to ensure unbiased results. During the 8-week study, participants will undergo skin biopsies from the upper arms and provide blood samples for plasma analysis. Dermatological assessments using photo-grading and bioanalytical blood tests will be performed to monitor skin health and circulating levels of Urolithin A. Safety will be assessed by recording any adverse events. Participants must adhere to study guidelines regarding skincare, sun exposure, and lifestyle habits throughout the trial.
CONDITIONS
Brief Title
A Double-Blind, Randomized, Double-Dummy, Active and Placebo-Controlled Clinical Study to Assess the Effect of an Oral Skin Supplement on Skin Health in Healthy Adults
Research Team
A
Anurag Singh, MD PhD
B
Brad Currier, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here